Get the Stockscreener App
12.03
0.91%
-0.11
Pre-market:
12.03
Angiodynamic Inc stock is traded at $12.03, with a volume of 320.62K.
It is down -0.91% in the last 24 hours and up +7.70% over the past month.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
See More
Previous Close:
$12.14
Open:
$12.1
24h Volume:
320.62K
Relative Volume:
0.69
Market Cap:
$488.83M
Revenue:
$324.01M
Net Income/Loss:
$-192.37M
P/E Ratio:
-2.5167
EPS:
-4.78
Net Cash Flow:
$-23.46M
1W Performance:
-2.51%
1M Performance:
+7.70%
6M Performance:
+29.49%
1Y Performance:
+79.82%
1-Day Range:
$11.92
$12.23
1-Week Range:
$11.92
$12.56
52-Week Range:
$6.61
$13.50
Angiodynamic Inc Stock (ANGO) Company Profile
Name
Angiodynamic Inc
Sector
Industry
Phone
(518) 798-1215
Address
14 PLAZA DRIVE, LATHAM
Compare ANGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
12.03 | 500.17M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
534.28 | 187.89B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
178.71 | 51.42B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.89 | 36.71B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
246.88 | 36.82B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
282.07 | 20.04B | 2.96B | 487.70M | 344.00M | 6.6758 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-16-25 | Initiated | Lake Street | Buy |
| Apr-05-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-25-23 | Initiated | H.C. Wainwright | Buy |
| Apr-17-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-15-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-20-21 | Initiated | Oppenheimer | Perform |
| Nov-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Apr-08-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-01-19 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-05-18 | Downgrade | Craig Hallum | Buy → Hold |
| Apr-07-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Mar-30-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Feb-08-17 | Initiated | Barclays | Equal Weight |
| Nov-04-16 | Initiated | Cantor Fitzgerald | Buy |
| Apr-08-16 | Resumed | Piper Jaffray | Neutral |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-24-15 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-19-14 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-09-12 | Reiterated | Canaccord Genuity | Hold |
| Jun-25-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-15-11 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-15-11 | Upgrade | Stifel Nicolaus | Hold → Buy |
| Jun-14-11 | Downgrade | Wedbush | Neutral → Underperform |
| Sep-08-10 | Reiterated | Wedbush | Neutral |
View All
Angiodynamic Inc Stock (ANGO) Latest News
AngioDynamics, Inc. $ANGO Stock Position Raised by Pier Capital LLC - MarketBeat
Why analysts upgrade AngioDynamics Inc. stockJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - fcp.pa.gov.br
Why analysts raise outlook for AngioDynamics Inc. (UG2) stockTrade Performance Summary & AI Driven Price Forecasts - fcp.pa.gov.br
AngioDynamics (NASDAQ: ANGO) to join UBS Global Healthcare Conference at 8:00 a.m. ET - Stock Titan
ANGO registers 4.7M plan shares and covers 2.53M insider resales - Stock Titan
What hedge fund activity signals for AngioDynamics Inc. stock2025 Volatility Report & Verified Entry Point Signals - newser.com
Will AngioDynamics Inc. stock continue dividend increasesWeekly Trade Summary & Consistent Income Trade Recommendations - Trung tâm Dự báo KTTV quốc gia
Insider Spends US$112k Buying More Shares In AngioDynamics - Yahoo Finance
Is AngioDynamics Inc. stock a good choice for value investors2025 Valuation Update & Precise Trade Entry Recommendations - Trung tâm Dự báo KTTV quốc gia
Ideas Watch: Will AngioDynamics Inc. stock return to pre crisis levels2025 Risk Factors & Low Drawdown Trading Strategies - Trung tâm Dự báo KTTV quốc gia
Why AngioDynamics Inc. (UG2) stock trades below fair valueJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
Day Trade: Is AngioDynamics Inc. stock a good choice for value investorsPortfolio Risk Summary & Long-Term Growth Portfolio Plans - Trung tâm Dự báo KTTV quốc gia
AngioDynamics, Inc. (ANGO) Stock Analysis: A 57.85% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
Time magazine names Latham-based AngioDynamics' cancer-fighting NanoKnife a top invention - Times Union
Published on: 2025-10-15 06:33:40 - newser.com
Analyzing AngioDynamics Inc. with multi timeframe chartsJuly 2025 Decliners & Smart Investment Allocation Insights - newser.com
Can technical indicators confirm AngioDynamics Inc.’s reversal - newser.com
Custom watchlist performance reports with AngioDynamics Inc.July 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions List - Stock Titan
AngioDynamics CEO, President & Director Acquires 1.9% More Stock - simplywall.st
AngioDynamics Inc (ANGO) CEO James Clemmer Purchases 10,000 Shar - GuruFocus
AngioDynamics Inc UG2 Stock Analysis and ForecastBreakout Stock Watch & Capital Efficiency Improvement - earlytimes.in
AngioDynamics Eyes Growth Despite Tariffs - Yahoo Finance
AngioDynamics (NASDAQ:ANGO) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
AngioDynamics Raises Forecast As Med Tech Sales Outperform - Finimize
ANGIODYNAMICS INC SEC 10-Q Report - TradingView
AngioDynamics Inc (ANGO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ... - Yahoo Finance
AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO) - Seeking Alpha
Why Did AngioDynamics Stock Pop Today? - The Motley Fool
Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results - Benzinga
AngioDynamics Inc reports results for the quarter ended August 31Earnings Summary - TradingView
Transcript : AngioDynamics, Inc., Q1 2026 Earnings Call, Oct 02, 2025 - MarketScreener
AngioDynamics, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 - MarketScreener
AngioDynamics Inc. Q1 Loss Decreases, Beats Estimates - Nasdaq
Stock Market Today: Dow Futures Slip, Nasdaq Rises Amid Mixed Trade—AngioDynamics, Entero Therapeutics, Fermi In FocusSPDR S&P 500 (ARCA:SPY) - Benzinga
Voya Investment Management LLC Has $103,000 Position in AngioDynamics, Inc. $ANGO - Defense World
AngioDynamics, Inc. Revises Earnings Guidance for the Full Fiscal Year 2026 - MarketScreener
Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 Earnings - Benzinga
Earnings To Watch: AngioDynamics Inc (ANGO) Reports Q1 2026 Result - Yahoo Finance
AngioDynamics Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
What drives AngioDynamics Inc stock pricePrice Volatility Patterns & Master Technical Analysis With Free Tools - earlytimes.in
Chart based analysis of AngioDynamics Inc. trendsJuly 2025 Fed Impact & Safe Swing Trade Setup Alerts - newser.com
Why AngioDynamics Inc. (UG2) stock signals breakout potentialJuly 2025 Institutional & Stepwise Swing Trade Plans - newser.com
Is AngioDynamics Inc. (UG2) stock a safe buy pre earningsMarket Performance Summary & AI Powered Market Entry Ideas - newser.com
How buyback programs support AngioDynamics Inc. (UG2) stock2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
What valuation ratios show for AngioDynamics Inc. (UG2) stock2025 Top Decliners & Weekly High Potential Stock Alerts - newser.com
Assenagon Asset Management S.A. Purchases 72,826 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
Angiodynamic Inc Stock (ANGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.60%
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):